Physician profile
Matthew Pollard
NPI 1407846728
$11,235.99
in general payments reported to CMS, 2019-2025
23 companies · $1,348 in 2025
The $1,348 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,997 · 2020: $242 · 2021: $1,519 · 2022: $1,417 · 2023: $2,833 · 2024: $1,880 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,400 · Travel and Lodging: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,399.92 |
| Travel and Lodging | $2,660.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $3,710.25 | 2019-2023 | Alif |
| Globus Medical, INC. | $2,186.05 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Excelsius3d Imaging System |
| Abbott Laboratories | $1,799.16 | 2022-2025 | Proclaim, Eterna, Penta |
| Medtronic, INC. | $1,498.97 | 2021-2025 | Kyphon Express II Kyphopak Tray, O-Arm, Intellis Adaptivestim |
| Stryker Corporation | $606.66 | 2023-2025 | Pangea, Variax, Aequalis Perform Reversed |
| Depuy Synthes Sales INC. | $474.25 | 2019-2025 | Va-Lcp, Na, Sentio |
| Vertex Pharmaceuticals Incorporated | $149.56 | 2025 | |
| Ethicon US, LLC | $135.98 | 2023-2024 | Dermabond Prineo, Vistaseal, Evarrest |
| 4web, INC. | $125.00 | 2022 | |
| Orthofix Medical, INC. | $108.77 | 2021-2025 | Physio-Stim |
| Zimvie INC. | $81.06 | 2022-2023 | |
| Medical Device Business Services, INC. | $70.48 | 2024 | Ethicon |
| Amgen INC. | $64.12 | 2019 | |
| Alafair Biosciences, INC. | $58.84 | 2025 | Versawrap |
| Lemaitre Vascular, INC. | $25.25 | 2025 | Anastoclip Gc 8cm (Medium) |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $24.38 | 2019 | |
| Tersera Therapeutics LLC | $23.46 | 2022 | |
| Misonix INC | $21.49 | 2019 | |
| Biocomposites INC | $18.25 | 2023 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $15.73 | 2019 | |
| Relievant Medsystems, INC. | $13.70 | 2019 | |
| Arteriocyte Medical Systems, INC. | $13.37 | 2024 | Magellan |
| Pfizer INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.